DE69020694D1 - Tricyclische Verbindungen. - Google Patents

Tricyclische Verbindungen.

Info

Publication number: DE69020694D1
Authority: DE; Germany
Prior art keywords: alkyl; amino; alkoxy; halogen; optionally substituted
Prior art date: 1989-11-28
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Lifetime

Application number

DE69020694T

Other languages

English (en)

Other versions

DE69020694T2 (de

Inventor

Jacob Berger

Robin D Clark

Richard M Eglen

William L Smith

Klaus K Weinhardt

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Roche Palo Alto LLC

Original Assignee

Syntex USA LLC

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-11-28

Filing date

1990-11-27

Publication date

1995-08-10

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23755479&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69020694(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1990-11-27 Application filed by Syntex USA LLC filed Critical Syntex USA LLC

1995-08-10 Application granted granted Critical

1995-08-10 Publication of DE69020694D1 publication Critical patent/DE69020694D1/de

1996-01-18 Publication of DE69020694T2 publication Critical patent/DE69020694T2/de

2010-11-28 Anticipated expiration legal-status Critical

Status Expired - Lifetime legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
- C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/14—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing 9-azabicyclo [3.3.1] nonane ring systems, e.g. granatane, 2-aza-adamantane; Cyclic acetals thereof
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/06—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing isoquinuclidine ring systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/06—Peri-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Hospice & Palliative Care (AREA)
Otolaryngology (AREA)
Cardiology (AREA)
Anesthesiology (AREA)
Rheumatology (AREA)
Nutrition Science (AREA)
Heart & Thoracic Surgery (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
Plural Heterocyclic Compounds (AREA)
Indole Compounds (AREA)
Saccharide Compounds (AREA)

DE69020694T 1989-11-28 1990-11-27 Tricyclische Verbindungen. Expired - Lifetime DE69020694T2 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US44208289A	1989-11-28	1989-11-28

Publications (2)

Publication Number	Publication Date
DE69020694D1 true DE69020694D1 (de)	1995-08-10
DE69020694T2 DE69020694T2 (de)	1996-01-18

Family

ID=23755479

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
DE69020694T Expired - Lifetime DE69020694T2 (de)	1989-11-28	1990-11-27	Tricyclische Verbindungen.
DE200512000027 Active DE122005000027I2 (de)	1989-11-28	1990-11-27	Tricyclische Verbindungen.

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
DE200512000027 Active DE122005000027I2 (de)	1989-11-28	1990-11-27	Tricyclische Verbindungen.

Country Status (23)

Country	Link
US (1)	US5202333A (de)
EP (1)	EP0430190B1 (de)
JP (1)	JPH0662607B2 (de)
KR (1)	KR970007917B1 (de)
AT (1)	ATE124698T1 (de)
AU (1)	AU642178B2 (de)
BR (1)	BR1100680A (de)
CA (1)	CA2030718C (de)
DE (2)	DE69020694T2 (de)
DK (1)	DK0430190T3 (de)
ES (1)	ES2075121T3 (de)
FI (1)	FI98367C (de)
HK (1)	HK36097A (de)
HU (1)	HU218654B (de)
IE (1)	IE68434B1 (de)
IL (2)	IL110622A (de)
LU (1)	LU91162I2 (de)
NL (1)	NL300194I2 (de)
NO (2)	NO175309C (de)
NZ (1)	NZ236225A (de)
PL (3)	PL166272B1 (de)
PT (1)	PT96001B (de)
ZA (1)	ZA909529B (de)

Families Citing this family (74)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PL166272B1 (pl) *	1989-11-28	1995-04-28	Syntex Inc	Sposób wytwarzania nowych addycyjnych soli z kwasami zwiazków trójpierscieniowych PL PL PL PL
US5491148A (en) *	1991-04-26	1996-02-13	Syntex (U.S.A.) Inc.	Isoquinolinone and dihydroisoquinolinone 5-HT3 receptor antagonists
EP1082959A1 (de) *	1991-09-20	2001-03-14	Glaxo Group Limited	NK1 Antagonisten zur Behandlung von Depression
US6582728B1 (en) *	1992-07-08	2003-06-24	Inhale Therapeutic Systems, Inc.	Spray drying of macromolecules to produce inhaleable dry powders
US6673335B1 (en) *	1992-07-08	2004-01-06	Nektar Therapeutics	Compositions and methods for the pulmonary delivery of aerosolized medicaments
ES2179831T3 (es) *	1992-09-29	2003-02-01	Inhale Therapeutic Syst	Liberacion en los pulmones de fragmentos activos de hormona paratiroidiana.
WO1995024183A1 (en) *	1994-03-07	1995-09-14	Inhale Therapeutic Systems	Methods and compositions for pulmonary delivery of insulin
US20030113273A1 (en) *	1996-06-17	2003-06-19	Patton John S.	Methods and compositions for pulmonary delivery of insulin
GB2288732B (en) *	1994-04-13	1998-04-29	Quadrant Holdings Cambridge	Pharmaceutical compositions
EP0759939B1 (de) *	1994-05-18	2005-07-20	Nektar Therapeutics	Methoden und zusammensetzungen für die trockenpuderarznei aus interferonen
US5567818A (en) *	1994-07-08	1996-10-22	Syntex (U.S.A.) Inc.	Processes for preparing 2-(1-azabicyclo[2.2.2]oct-3-yl)-1H-benz[de] isoquinolin-1-one derivatives and intermediates useful therein
US5510486A (en) *	1994-07-26	1996-04-23	Syntex (U.S.A.) Inc.	Process for preparing 2-(1-azabicyclo 2.2.2!oct-3-yl)-2,3,3A,4,5,6-hexahydro-1H-benz de!isoquinolin-1-one
US5492914A (en) *	1994-07-28	1996-02-20	Syntex (U.S.A.) Inc.	2-(1-azabicyclo[2.2.2]oct-3 s-yl)-6-hydroxy-2,4,5,6-tetrahydro-1H-benz[DE]is[2.2.2]oct-3's-yl)-6-hydroxy-2,3,3a,4,5,6-hexahydro-1h-benz [DE]isoquinolin-1-one and individual stereoisomers thereof
US6290991B1 (en)	1994-12-02	2001-09-18	Quandrant Holdings Cambridge Limited	Solid dose delivery vehicle and methods of making same
US5723103A (en) *	1994-12-09	1998-03-03	Vanderbilt University	Substituted benzamides and radioligand analogs and methods of use
US20030035778A1 (en) *	1997-07-14	2003-02-20	Robert Platz	Methods and compositions for the dry powder formulation of interferon
US6565885B1 (en) *	1997-09-29	2003-05-20	Inhale Therapeutic Systems, Inc.	Methods of spray drying pharmaceutical compositions
US20060165606A1 (en)	1997-09-29	2006-07-27	Nektar Therapeutics	Pulmonary delivery particles comprising water insoluble or crystalline active agents
US6309623B1 (en) *	1997-09-29	2001-10-30	Inhale Therapeutic Systems, Inc.	Stabilized preparations for use in metered dose inhalers
JP2002537245A (ja) *	1999-02-18	2002-11-05	ノバルティスアクチエンゲゼルシャフト	５−ｈｔ３レセプターアンタゴニストの使用
US8404217B2 (en)	2000-05-10	2013-03-26	Novartis Ag	Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
TWI290473B (en)	2000-05-10	2007-12-01	Alliance Pharma	Phospholipid-based powders for drug delivery
US7871598B1 (en)	2000-05-10	2011-01-18	Novartis Ag	Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
US20050042194A1 (en) *	2000-05-11	2005-02-24	A.P. Pharma, Inc.	Semi-solid delivery vehicle and pharmaceutical compositions
JP2003533482A (ja) *	2000-05-18	2003-11-11	グラクソグループリミテッド	機能性消化不良の治療方法
KR20040100835A (ko)	2001-02-15	2004-12-02	킹 파머슈티칼스 리서치 앤드 디벨로프먼트 아이엔씨	안정된 제약및 갑상선 내분비 호르몬 구성물 및 그제조방법
US7101569B2 (en)	2001-08-14	2006-09-05	Franz G Andrew	Methods of administering levothyroxine pharmaceutical compositions
WO2003053411A1 (en)	2001-12-19	2003-07-03	Nektar Therapeutics	Pulmonary delivery of aminoglycosides
WO2003072578A1 (en) *	2002-02-20	2003-09-04	Pharmacia & Upjohn Company	Azabicyclic compounds with alfa7 nicotinic acetylcholine receptor activity
US20030187017A1 (en) *	2002-11-14	2003-10-02	Mangel Allen Wayne	Method for treating functional dyspepsia
AU2003302072A1 (en) *	2002-11-15	2004-06-15	Helsinn Healthcare Sa	Palonosetron for the treatment of chemotherapy-induced emesis
US8598219B2 (en)	2003-01-30	2013-12-03	Helsinn Healthcare Sa	Liquid pharmaceutical formulations of palonosetron
JO2735B1 (en) *	2003-01-30	2013-09-15	هيلسين هيلث كير أس ايه.	Liquid pharmaceutical formations of balloonosterone
MY143789A (en) *	2003-02-18	2011-07-15	Helsinn Healthcare Sa	Use of palonosetron treating post- operative nausea and vomiting
US20060167072A1 (en) *	2004-01-30	2006-07-27	Helsinn Healthcare Sa	Liquid pharmaceutical formulations of palonosetron
CN100336508C (zh) *	2005-02-23	2007-09-12	重庆医药工业研究院有限责任公司	一种稳定的帕洛诺司琼注射液
US20070031342A1 (en) *	2005-06-22	2007-02-08	Nektar Therapeutics	Sustained release microparticles for pulmonary delivery
US20080004260A1 (en) *	2006-06-29	2008-01-03	Transcept Pharmaceuticals, Inc.	Compositions of 5-HT3 antagonists and dopamine D2 antagonists for treatment of dopamine-associated chronic conditions
US8614225B2 (en) *	2006-08-30	2013-12-24	Dr. Reddy's Laboratories Limited	Process for the purification of palonosetron or its salt
US7737280B2 (en)	2006-10-23	2010-06-15	Sicor Inc.	Processes for preparing palonosetron salts
HRP20090341T1 (hr) *	2006-10-24	2009-07-31	Helsinn Healthcare S.A.	Mekane kapsule koje sadrže palonosetron hidroksiklorid s poboljšanom stabilnosti i bioraspoloživosti
EP2099298A4 (de) *	2006-12-07	2010-01-06	Helsinn Healthcare Sa	Kristalline und amorphe formen von palonosetron-hydrochlorid
WO2008146283A2 (en) *	2007-05-29	2008-12-04	Chemagis Ltd.	Novel palonosetron salts and processes for preparation and purification thereof
US20090227623A1 (en) *	2007-09-15	2009-09-10	Protia, Llc	Deuterium-enriched palosetron
CN101157691B (zh) *	2007-10-18	2011-01-12	杭州九源基因工程有限公司	一种盐酸帕洛诺司琼的生产工艺
AR069625A1 (es) *	2007-12-13	2010-02-03	Glenmark Generics Ltd	Base libre de palonosetron y procedimiento para su preparacion
WO2009087643A1 (en) *	2008-01-11	2009-07-16	Natco Pharma Limited	Novel crystalline forms of palonosetron hydrochloride
WO2009136405A1 (en) *	2008-05-05	2009-11-12	Natco Pharma Limited	High purity palonosetron base and its solid state characteristics
US20100048607A1 (en) *	2008-08-25	2010-02-25	Chandrashekhar Kocherlakota	Formulations comprising palonosetron
US20100099701A1 (en) *	2008-10-20	2010-04-22	Auspex Pharmaceuticals, Inc.	Isoquinolinone modulators of 5-ht3 receptors
WO2010056656A2 (en) *	2008-11-11	2010-05-20	Dr. Reddy's Laboratories Ltd.	Preparation of crystalline palonosetron hydrochloride
WO2010077669A2 (en)	2008-12-08	2010-07-08	Teva Pharmaceutical Industries Ltd.	Palonosetron formulation
EP2370064A4 (de) *	2008-12-11	2012-09-19	A P Pharma Inc	Verfahren zur erhöhung der stabilität von polyorthoestern und ihren formulierungen
CN101851233B (zh) *	2009-04-03	2013-03-06	四川滇虹医药开发有限公司	盐酸帕洛诺司琼和其前体化合物及制备
CN101849904A (zh) *	2009-04-03	2010-10-06	南京长澳医药科技有限公司	一种帕洛诺司琼注射液及其制备方法
US20100298397A1 (en) *	2009-05-19	2010-11-25	Singh Nikhilesh N	Method of treatment of obsessive compulsive disorder with ondansetron
KR101779991B1 (ko)	2009-05-20	2017-09-19	인쎄름 (엥스띠뛰 나씨오날 드 라 쌍떼 에 드 라 흐쉐르슈 메디깔)	병소성 전정 질환을 치료하기 위한 세로토닌 5-ｈｔ3 수용체 길항제의 용도
ES2432618T3 (es)	2009-05-20	2013-12-04	Inserm (Institut National De La Santé Et De La Recherche Medicale)	Antagonistas del receptor 5-HT3 de serotonina para usar en el tratamiento o prevención de una patología del oído interno con déficit vestibular
EP2448936A2 (de)	2009-06-30	2012-05-09	Ranbaxy Laboratories Limited	Verfahren zur herstellung von palonosetronhydrochlorid form i und form ii
CA2767233A1 (en)	2009-07-14	2011-01-20	Albany Molecular Research, Inc.	5-ht3 receptor modulators, methods of making, and use thereof
WO2011013095A1 (en)	2009-07-31	2011-02-03	Ranbaxy Laboratories Limited	Processes for the preparation of palonosetron
US20120253046A1 (en) *	2009-11-13	2012-10-04	Helsinn Healthcare S.A.	Palonosetron metabolites
EP2722045B1 (de)	2009-11-18	2016-07-06	Helsinn Healthcare SA	Zusammensetzungen zur Behandlung von zentral vermitteltem Unwohlsein und Erbrechen
EP2361090B1 (de)	2009-11-18	2014-05-21	Helsinn Healthcare SA	Zusammensetzungen zur behandlung von zentral vermitteltem unwohlsein und erbrechen
EP2744497B1 (de)	2011-10-18	2016-04-06	Helsinn Healthcare SA	Therapeutische kombinationen aus netupitant und palonosetron
CN102688185B (zh) *	2012-06-01	2013-07-10	齐鲁制药(海南)有限公司	一种稳定的帕洛诺司琼注射液及其制备方法
WO2015099381A1 (ko)	2013-12-23	2015-07-02	주식회사 삼양바이오팜	팔로노세트론을 함유하는 약학 조성물
US20180250270A1 (en)	2015-09-11	2018-09-06	Chase Pharmaceuticals Corporation	Muscarinic combination and its use for combating hypocholinergic disorders of the central nervous system
WO2018200387A1 (en)	2017-04-24	2018-11-01	Chase Therapeutics Corporation	Compositions and method for treating depression
EP3672964A4 (de)	2017-08-21	2021-05-26	Leiutis Pharmaceuticals Pvt. Ltd.	Neuartige dreifachkombinationsformulierungen für antiemetische therapie
EP4385497A1 (de)	2022-12-12	2024-06-19	Alfred E. Tiefenbacher (GmbH & Co. KG)	Antioxidansfreie festdosiskombination aus netupitant und palonosetron
WO2024126408A1 (en)	2022-12-12	2024-06-20	Alfred E. Tiefenbacher (Gmbh & Co. Kg)	Antioxidant-free fixed dose combination of netupitant and palonosetron
EP4385500A1 (de)	2022-12-12	2024-06-19	Alfred E. Tiefenbacher (GmbH & Co. KG)	Festdosiskombination mit netupitant und palonosetron
EP4633612A1 (de)	2022-12-12	2025-10-22	Alfred E. Tiefenbacher (GmbH & Co. KG)	Festdosiskombination mit netupitant und palonosetron

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3341528A (en) *	1963-11-07	1967-09-12	Warner Lambert Pharmaceutical	Substituted benzoquinolines
US3896132A (en) *	1969-08-19	1975-07-22	Hoffmann La Roche	Process for preparing 1,2,3,8,9,9a-hexahydro-5,6-dialkoxy-1-alkyl-benzo(d,e)quinolin-7-ore compounds
US4309543A (en) *	1980-03-17	1982-01-05	Dynapol	Process for preparing cyclic amides
EP0093488A3 (de) *	1982-03-18	1984-05-23	Beecham Group Plc	Nortropyl-Benzopyrrolinon-Verbindungen, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
US4571396A (en) *	1984-04-16	1986-02-18	Warner-Lambert Company	Antibacterial agents
WO1988004292A1 (en) *	1986-12-11	1988-06-16	The Upjohn Company	Antipsychotic amino-polyhydro-benz-(iso)quinolines and intermediates
EP0315390B1 (de) *	1987-11-04	1994-07-20	Beecham Group Plc	Neue 4-Oxobenzotriazine und 4-Oxochinazoline
PL166272B1 (pl) *	1989-11-28	1995-04-28	Syntex Inc	Sposób wytwarzania nowych addycyjnych soli z kwasami zwiazków trójpierscieniowych PL PL PL PL
AU7618991A (en) *	1990-05-14	1991-11-14	Syntex (U.S.A.) Inc.	Novel tricyclic compounds
US5189041A (en) *	1990-11-16	1993-02-23	Syntex (U.S.A.) Inc.	Tricyclic 5-ht3 receptor antagonists

1990
- 1990-11-27 PL PL90287961A patent/PL166272B1/pl unknown
- 1990-11-27 DE DE69020694T patent/DE69020694T2/de not_active Expired - Lifetime
- 1990-11-27 PL PL90303660A patent/PL166267B1/pl unknown
- 1990-11-27 DE DE200512000027 patent/DE122005000027I2/de active Active
- 1990-11-27 JP JP2328764A patent/JPH0662607B2/ja not_active Expired - Fee Related
- 1990-11-27 AU AU66963/90A patent/AU642178B2/en not_active Expired
- 1990-11-27 PL PL90303661A patent/PL166277B1/pl unknown
- 1990-11-27 AT AT90122689T patent/ATE124698T1/de active
- 1990-11-27 EP EP90122689A patent/EP0430190B1/de not_active Expired - Lifetime
- 1990-11-27 ZA ZA909529A patent/ZA909529B/xx unknown
- 1990-11-27 NZ NZ236225A patent/NZ236225A/en unknown
- 1990-11-27 CA CA002030718A patent/CA2030718C/en not_active Expired - Lifetime
- 1990-11-27 IL IL11062290A patent/IL110622A/en not_active IP Right Cessation
- 1990-11-27 IE IE426990A patent/IE68434B1/en not_active IP Right Cessation
- 1990-11-27 KR KR1019900019275A patent/KR970007917B1/ko not_active Expired - Lifetime
- 1990-11-27 DK DK90122689.4T patent/DK0430190T3/da active
- 1990-11-27 ES ES90122689T patent/ES2075121T3/es not_active Expired - Lifetime
- 1990-11-27 PT PT96001A patent/PT96001B/pt not_active IP Right Cessation
- 1990-11-27 HU HU670/90A patent/HU218654B/hu active Protection Beyond IP Right Term
- 1990-11-27 IL IL9648690A patent/IL96486A/en active Protection Beyond IP Right Term
- 1990-11-27 FI FI905839A patent/FI98367C/fi active Protection Beyond IP Right Term
- 1990-11-27 NO NO905120A patent/NO175309C/no not_active IP Right Cessation
1991
- 1991-05-22 US US07/704,565 patent/US5202333A/en not_active Expired - Lifetime
1997
- 1997-03-20 HK HK36097A patent/HK36097A/en not_active IP Right Cessation
- 1997-05-08 BR BR1100680-3A patent/BR1100680A/pt active IP Right Grant
2005
- 2005-04-18 LU LU91162C patent/LU91162I2/fr unknown
- 2005-04-20 NL NL300194C patent/NL300194I2/nl unknown
- 2005-09-21 NO NO2005023C patent/NO2005023I2/no unknown

Also Published As

Publication number	Publication date
FI905839A0 (fi)	1990-11-27
BR1100680A (pt)	2000-02-08
IE904269A1 (en)	1991-06-05
ES2075121T3 (es)	1995-10-01
US5202333A (en)	1993-04-13
JPH03176486A (ja)	1991-07-31
FI905839L (fi)	1991-05-29
DK0430190T3 (da)	1995-08-21
NO175309B (no)	1994-06-20
IL96486A0 (en)	1991-08-16
JPH0662607B2 (ja)	1994-08-17
NO2005023I1 (no)	2005-10-03
HU907660D0 (en)	1991-06-28
DE122005000027I2 (de)	2006-03-16
KR910009699A (ko)	1991-06-28
PL166277B1 (pl)	1995-04-28
FI98367C (fi)	1997-06-10
DE69020694T2 (de)	1996-01-18
PT96001B (pt)	1998-01-30
NO905120L (no)	1991-05-29
ZA909529B (en)	1992-08-26
CA2030718C (en)	1998-05-12
NL300194I1 (nl)	2005-07-01
LU91162I2 (fr)	2005-06-20
PT96001A (pt)	1991-09-30
PL166272B1 (pl)	1995-04-28
HK36097A (en)	1997-03-27
NZ236225A (en)	1992-09-25
NO905120D0 (no)	1990-11-27
IL110622A (en)	1995-03-30
AU6696390A (en)	1991-06-06
NO2005023I2 (no)	2009-10-05
NL300194I2 (nl)	2005-07-01
PL287961A1 (en)	1991-12-02
IL96486A (en)	1995-03-30
EP0430190A3 (en)	1992-01-22
PL166267B1 (pl)	1995-04-28
KR970007917B1 (ko)	1997-05-17
AU642178B2 (en)	1993-10-14
EP0430190B1 (de)	1995-07-05
ATE124698T1 (de)	1995-07-15
HU218654B (hu)	2000-10-28
CA2030718A1 (en)	1991-05-29
DE122005000027I1 (de)	2005-08-04
EP0430190A2 (de)	1991-06-05
IE68434B1 (en)	1996-06-12
NO175309C (no)	1994-09-28
HUT56368A (en)	1991-08-28
FI98367B (fi)	1997-02-28

Publication	Publication Date	Title
ATE124698T1 (de)	1995-07-15	Tricyclische verbindungen.
EA200100553A1 (ru)	2001-12-24	Замещенные бициклические производные, полезные в качестве противораковых агентов
EA200000592A1 (ru)	2000-12-25	Азаполициклические соединения, конденсированные с арилом
KR900012911A (ko)	1990-09-03	흥분성 아미노산 수용기 길항질 화합물
EA200000731A1 (ru)	2001-02-26	Альфа-аминоамидные производные, полезные в качестве анальгетических агентов
EA199800794A1 (ru)	1999-04-29	Новые производные арилглициламида, способ их получения и фармацевтическая композиция, содержащая эти соединения
PT753301E (pt)	2003-08-29	Combinacao de um benzimidazole tendo actividade antagonista da angiotensina ii com um diuretico
TR199801782T2 (xx)	1998-12-21	Kinoksalindionlar
RU95104939A (ru)	1996-10-27	Тетрациклические соединения, способ их получения и промежуточные соединения для этого и применение их в качестве противоопухолевых веществ
ID25477A (id)	2000-10-05	Turunan-turunan spiropiperidin
EP0604352A3 (de)	1995-02-08	Arylsubstituierte heterocyclische Verbindungen.
EP0604355A3 (de)	1995-02-08	Alkylsubstituierte heterocyclische Verbindungen.
TW334428B (en)	1998-06-21	Novel benzodiazepine derivatives
DK189389A (da)	1989-10-21	Heterotetracycliske lactamderivater
ATE151750T1 (de)	1997-05-15	3-(indol-3-yl) propensäurderivate, die als nmda- antagonisten nützlich sind
WO1997029077A1 (fr)	1997-08-14	Derives amides substitues

Legal Events

Date	Code	Title	Description
1996-08-08	8364	No opposition during term of opposition
2004-05-27	8327	Change in the person/name/address of the patent owner	Owner name: ROCHE PALO ALTO LLC, PALO ALTO, CALIF., US
2005-05-03	V448	Application of spc	Free format text: PRODUCT NAME: PALONOSETRON (ALS HYDROCHLORID); REGISTRATION NO/DATE: EU/1/04/306/001, 20050322 Spc suppl protection certif: 12 2005 000 027 Filing date: 20050503
2005-11-28	V484	Delivery of the decision of grant	Free format text: PRODUCT NAME: PALONOSETRON (ALS HYDROCHLORID); REGISTRATION NO/DATE: EU/1/04/306/001, 20050322 Spc suppl protection certif: 12 2005 000 027 Filing date: 20050503
2005-12-28	V457	Spc granted	Free format text: PRODUCT NAME: PALONOSETRON (ALS HYDROCHLORID); REGISTRATION NO/DATE: EU/1/04/306/001, 20050322 Spc suppl protection certif: 12 2005 000 027 Filing date: 20050503
2014-02-04	R082	Change of representative	Free format text: PRODUCT NAME: PALONOSETRON UND DESSEN ISOMERE, SALZE UND ESTER; REGISTRATION NO/DATE: EU/1/04/306/001 20050322 Spc suppl protection certif: 122005000027 Filing date: 20050503 Expiry date: 20101128 Representative=s name: MEISSNER, BOLTE & PARTNER GBR, DE Extension date: 20151127
2015-11-27	R071	Expiry of right	Free format text: PRODUCT NAME: PALONOSETRON UND DESSEN ISOMERE, SALZE UND ESTER; REGISTRATION NO/DATE: EU/1/04/306/001 20050322 Spc suppl protection certif: 122005000027 Filing date: 20050503 Expiry date: 20101128 Extension date: 20151127